Table 1.
Patient characteristics among women with ESKD of childbearing age, by delivery status and modality of kidney replacement therapy, 2002–2015
| Hemodialysis | Peritoneal Dialysis | Transplant | Unknown1 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| No Delivery (n= 11,718) | 1+ Delivery (n= 664) | p-value2 | No Delivery (n= 3,225) | 1+ Delivery (n= 47) | p-value2 | No Delivery (n= 25,446) | 1+ Delivery (n= 670) | p-value2 | No Delivery (n= 79585) | 1+ Delivery (n=226) | p-value2 | |
| Age, y | 37.5 | 30.6 | <0.001 | 36.1 | 30.1 | <0.001 | 35.5 | 30.5 | <0.001 | 36.4 | 29.9 | <0.001 |
| Race (%) | <0.0013 | 0.033 | <0.0013 | <0.0013 | ||||||||
| White | 46.8% | 38.6% | 59.4% | 40% | 76.6% | 71.2% | 53.0% | 38.3% | ||||
| Black | 46.1% | 52.6% | 30.8% | 48% | 13.5% | 20.5% | 39.0% | 54.2% | ||||
| Asian | 3.2% | 3.1% | 6.4% | 10% | 4.5% | 4.9% | 3.1% | 1.9% | ||||
| Other | 3.8% | 5.7% | 3.5% | 2% | 5.4% | 3.4% | 4.7% | 5.6% | ||||
| Hispanic | 15.6% | 24.5% | <0.001 | 17.0% | 28% | 0.06 | 16.6% | 27.2% | <0.001 | 17.9% | 17.0% | 0.7 |
| KRT Vintage (y) | 7.1 | 4.4 | <0.001 | 2.5 | 7 | <0.001 | 9.6 | 8.2 | <0.001 | 1.7 | 1.9 | .2 |
| Cause of kidney failure (%) | <0.0014 | <0.0014 | <0.0014 | <0.0014 | ||||||||
| DM | 30.0% | 12.5% | 24.4% | 6% | 18.9% | 9.6% | 31.1% | 15.4% | ||||
| HTN | 19.8% | 22.9% | 15.2% | 17% | 6.9% | 7.5% | 17.5% | 16.8% | ||||
| GN | 30.1% | 47.1% | 39.6% | 52% | 37.1% | 55.1% | 21.5% | 39.3% | ||||
| Cystic Kidney | 2.6% | 2.2% | 4.5% | 0% | 5.7% | 4.0% | 3.2% | 2.3% | ||||
| Other Urologic | 2.1% | 1.9% | 2.5% | 0% | 4.0% | 4.7% | 1.2% | 0.9% | ||||
| Other | 10.3% | 6.7% | 9.4% | 10% | 16.0% | 13.2% | 16.4% | 19.6% | ||||
| Unknown | 3.9% | 5.7% | 4% | 15% | 6.0% | 5.0% | 4.7% | 4.2% | ||||
| Missing | 0.5% | 1.0% | 0.5% | 0% | 5.5% | 0.9% | 4.1% | 1.4% | ||||
| Comorbidities | ||||||||||||
| ASHD | 23.0% | 16.3% | <0.001 | 21.9% | 11% | 0.02 | 8.0% | 4.6% | <0.001 | 13.0% | 15.0% | .4 |
| CHF | 31.3% | 32.7% | 0.4 | 38.9% | 22% | 0.2 | 8.4% | 8.7% | 0.8 | 18.0% | 25.2% | 0.01 |
| CVA | 13.6% | 8.6% | <0.001 | 13.2% | 6% | 0.06 | 4.2% | 3.1% | 0.08 | 7.8% | 8.5% | .7 |
| PVD | 33.4% | 30.8% | .2 | 29.3% | 21% | 0.09 | 11.6% | 11.8% | 0.8 | 18.8% | 18.0% | .8 |
| Other CVD | 40.4% | 50.5% | <0.001 | 40.0% | 45% | 0.5 | 14.9% | 21.7% | <0.001 | 22.7% | 35.6% | <0.001 |
| Anemia | 73.7% | 96.5% | <0.001 | 79.5% | 96% | <0.001 | 33.6% | 68.3% | <0.001 | 51.4% | 79.8% | <0.001 |
Data is presented by woman across all years of the study period.
1
Unknown refers to “uncertain dialysis” or “missing” modality.
2
p-values from chi-squared test for categorical variables and t-test for continuous variables.
3
p-value for race (degrees of freedom = 3).
4
p-value for cause (degrees of freedom = 8).
GN: Glomerulonephritis. ASHD: Atherosclerotic heart disease. CHF: Congestive heart failure. CVA: Cerebrovascular accident. PVD: Peripheral vascular disease. CVD: Cardiovascular disease; KRT, kidney replacement therapy; HTN, hypertension; DM, diabetes mellitus.